Page last updated: 2024-08-25

doripenem and Bacteremia

doripenem has been researched along with Bacteremia in 13 studies

Research

Studies (13)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (7.69)29.6817
2010's11 (84.62)24.3611
2020's1 (7.69)2.80

Authors

AuthorsStudies
Abdelraouf, K; Ameka, M; Brioso, CG; Caeiro, JP; Chang, KT; Garey, KW; McCaskey, LA; Tam, VH; Weston, JS1
Fukuda, H; Hashimoto, T; Hashinaga, K; Hayashidani, H; Nureki, SI; Sakamoto, T; Shigemitsu, O; Takenaka, R1
Kaniga, K; Lee, M; Redman, R; Rice, DA1
Baziaka, F; Galani, L; Giamarellou, H; Karaiskos, I1
Caio, C; Ceccarelli, G; Falcone, M; Giordano, A; Mezzatesta, ML; Stefani, S; Venditti, M1
Chen, L; Clancy, CJ; Clarke, LG; Eschenauer, GA; Kreiswirth, BN; Nguyen, MH; Potoski, BA; Press, EG; Shields, RK1
Fujiya, Y; Hayakawa, K; Kutsuna, S; Mawatari, M; Mezaki, K; Nagamatsu, M; Ohmagari, N; Takeshita, N; Tamura, S; Yamamoto, K1
Cacciarelli, TV; Muder, RR; Shields, RK; Singh, N; Sun, HY1
Ko, KS; Lee, H; Peck, KR; Song, JH1
Akalın, H; Akova, M; Arman, D; Aygen, B; Başaran, S; Bayramoğlu, G; Dizbay, M; Dokuzoğuz, B; Eraksoy, H; Esener, H; Hasçelik, G; Köksal, I; Korten, V; Oğünç, D; Sınırtaş, M; Söyletir, G; Sümerkan, B; Tünger, A; Ulusoy, S; Yalçın, AN1
Decker-Burgard, S; Laeuffer, J; Morrissey, I; Mutters, R; Seifert, H; Valenza, G1
Chang, SC; Dong, SX; Wang, JT1
Kobayashi, Y1

Reviews

1 review(s) available for doripenem and Bacteremia

ArticleYear
Septic shock due to Yersinia pseudotuberculosis infection in an adult immunocompetent patient: a case report and literature review.
    BMC infectious diseases, 2021, Jan-07, Volume: 21, Issue:1

    Topics: Adult; Anti-Bacterial Agents; Azithromycin; Bacteremia; Blood Culture; Cefmetazole; Ceftriaxone; Doripenem; Fever; Humans; Immunocompetence; Male; Pneumonia, Bacterial; Shock, Septic; Yersinia pseudotuberculosis; Yersinia pseudotuberculosis Infections

2021

Trials

1 trial(s) available for doripenem and Bacteremia

ArticleYear
Activity of doripenem versus comparators in subjects with baseline bacteraemia in six pooled phase 3 clinical trials.
    International journal of antimicrobial agents, 2013, Volume: 41, Issue:4

    Topics: Anti-Bacterial Agents; Bacteremia; Carbapenems; Cross Infection; Doripenem; Female; Humans; Imipenem; Intraabdominal Infections; Male; Meropenem; Ofloxacin; Pneumonia; Thienamycins; Treatment Outcome; Urinary Tract Infections

2013

Other Studies

11 other study(ies) available for doripenem and Bacteremia

ArticleYear
Prevalence, resistance mechanisms, and susceptibility of multidrug-resistant bloodstream isolates of Pseudomonas aeruginosa.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:3

    Topics: Anti-Bacterial Agents; Bacteremia; Bacterial Proteins; Cross Infection; Drug Resistance, Multiple, Bacterial; Hospitals, University; Humans; Microbial Sensitivity Tests; Prevalence; Pseudomonas aeruginosa; Pseudomonas Infections; Texas

2010
Effectiveness of a double-carbapenem regimen for infections in humans due to carbapenemase-producing pandrug-resistant Klebsiella pneumoniae.
    Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:5

    Topics: Adult; Anti-Bacterial Agents; Bacteremia; Bacterial Proteins; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Carbapenems; Doripenem; Drug Combinations; Drug Resistance, Bacterial; Ertapenem; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Meropenem; Middle Aged; Thienamycins; Treatment Outcome; Urinary Tract Infections

2013
Successful ertapenem-doripenem combination treatment of bacteremic ventilator-associated pneumonia due to colistin-resistant KPC-producing Klebsiella pneumoniae.
    Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:6

    Topics: Aged; Anti-Bacterial Agents; Bacteremia; beta-Lactams; Carbapenems; Colistin; Doripenem; Drug Resistance, Bacterial; Drug Therapy, Combination; Ertapenem; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Pneumonia, Ventilator-Associated; Treatment Outcome

2013
Doripenem MICs and ompK36 porin genotypes of sequence type 258, KPC-producing Klebsiella pneumoniae may predict responses to carbapenem-colistin combination therapy among patients with bacteremia.
    Antimicrobial agents and chemotherapy, 2015, Volume: 59, Issue:3

    Topics: Adult; Aged; Anti-Bacterial Agents; Bacteremia; Bacterial Proteins; beta-Lactamases; Carbapenems; Colistin; Doripenem; Drug Therapy, Combination; Female; Genotype; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Porins; Retrospective Studies

2015
Bacteremia Due to Arthrobacter creatinolyticus in an Elderly Diabetic Man with Acute Cholangitis.
    Japanese journal of infectious diseases, 2017, Mar-24, Volume: 70, Issue:2

    Topics: Aerobiosis; Aged, 80 and over; Ampicillin; Anti-Bacterial Agents; Arthrobacter; Bacteremia; beta-Lactamase Inhibitors; Carbapenems; Cholangitis; Diabetes Complications; DNA, Bacterial; DNA, Ribosomal; Doripenem; Gram-Positive Bacterial Infections; Humans; Male; RNA, Ribosomal, 16S; Sequence Analysis, DNA; Sulbactam

2017
A novel combination regimen for the treatment of refractory bacteremia due to multidrug-resistant Pseudomonas aeruginosa in a liver transplant recipient.
    Transplant infectious disease : an official journal of the Transplantation Society, 2010, Volume: 12, Issue:6

    Topics: Anti-Bacterial Agents; Bacteremia; Bile Duct Diseases; Carbapenems; Colistin; Doripenem; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Humans; Liver Transplantation; Male; Microbial Sensitivity Tests; Middle Aged; Pseudomonas aeruginosa; Pseudomonas Infections; Tobramycin; Treatment Outcome

2010
Antimicrobial activity of doripenem and other carbapenems against gram-negative pathogens from Korea.
    Microbial drug resistance (Larchmont, N.Y.), 2011, Volume: 17, Issue:1

    Topics: Anti-Bacterial Agents; Bacteremia; Carbapenems; Doripenem; Drug Resistance, Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Imipenem; Korea; Meropenem; Microbial Sensitivity Tests; Republic of Korea; Thienamycins; Urinary Tract Infections

2011
[Comparative evaluation of in vitro activities of carbapenems against gram-negative pathogens: Turkish data of COMPACT study].
    Mikrobiyoloji bulteni, 2011, Volume: 45, Issue:2

    Topics: Anti-Bacterial Agents; Bacteremia; Carbapenems; Cross Infection; Doripenem; Drug Resistance, Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Imipenem; Intensive Care Units; Meropenem; Microbial Sensitivity Tests; Pneumonia, Bacterial; Thienamycins; Turkey

2011
Comparative Activity of Carbapenem Testing (COMPACT) study in Germany.
    International journal of antimicrobial agents, 2012, Volume: 39, Issue:3

    Topics: Bacteremia; Carbapenems; Cross Infection; Doripenem; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Germany; Humans; Imipenem; Intensive Care Units; Intraabdominal Infections; Meropenem; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Quality Control; Thienamycins

2012
Activities of doripenem against nosocomial bacteremic drug-resistant Gram-negative bacteria in a medical center in Taiwan.
    Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi, 2012, Volume: 45, Issue:6

    Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Bacteremia; Carbapenems; Cross Infection; Doripenem; Drug Resistance, Bacterial; Enterobacteriaceae; Gram-Negative Bacteria; Hospitals, University; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Taiwan; Thienamycins

2012
Study of the synergism between carbapenems and vancomycin or teicoplanin against MRSA, focusing on S-4661, a carbapenem newly developed in Japan.
    Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2005, Volume: 11, Issue:5

    Topics: Anti-Bacterial Agents; Bacteremia; Carbapenems; Doripenem; Drug Resistance, Bacterial; Drug Synergism; Drug Therapy, Combination; Humans; Japan; Methicillin Resistance; Microbial Sensitivity Tests; Staphylococcal Infections; Staphylococcus aureus; Teicoplanin; Vancomycin

2005